Literature DB >> 6149767

Characterization of somatostatin binding sites in cytosolic fraction of rat intestinal mucosa.

E Arilla, M P Lopez-Ruiz, L Gonzalez Guijarro, J C Prieto, A Gomez-Pan, B Hirst.   

Abstract

Specific binding sites for somatostatin have been characterized in cytosolic fraction of rat intestinal mucosa by using 125I-labelled Tyr11-somatostatin and a variety of physicochemical conditions. The binding depended on time, temperature and pH, and was reversible, saturable and specific. At apparent equilibrium, the specific binding of 125I-Tyr11-somatostatin was competitively inhibited by native somatostatin in the 1 nM-4 microM concentration range. Binding studies suggested the presence of two classes of binding sites: a class with high affinity (Kd = 0.07 microM) and low capacity (4.6 pmol/mg protein) and a class with low affinity (Kd = 1.05 microM) and high capacity (277 pmol/mg protein) at 25 degrees C. Somatostatin exhibited competitive inhibition of tracer binding, while neuropeptides such as neurotensin, substance P, Leu-enkephalin, and vasoactive intestinal peptide were ineffective. The presence of somatostatin binding sites in cytosolic fraction of intestinal mucosa, together with the known occurrence of somatostatin in D-cells and nerve endings in the small intestine, strongly suggest that this peptide may be involved in the physiology and physiopathology of intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149767     DOI: 10.1016/0304-4165(84)90162-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Effects of fasting and refeeding on somatostatin concentration and binding to cytosol from rabbit gastric mucosa.

Authors:  B Roca; R Fernandez-Valencia; E Arilla
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

2.  Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin.

Authors:  J Nelson; M Cremin; R F Murphy
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.